EE50 A Cost-Consequence Model of Using the 21-Gene Breast Recurrence Score Assay to Identify Patients With Early-Stage Node-Positive Breast Cancer Who Benefit From Adjuvant Chemotherapy in the Netherlands
Machielsen, P, de Jongh, FE, Drost, P, Simons, M, Spoorendonk, JA
Published in Value in health (01.12.2022)
Published in Value in health (01.12.2022)
Get full text
Journal Article
POSB97 Cost-Consequence Model of Using Gene Expression Tests in Patients with Early Breast Cancer in the Netherlands
de Jongh, FE, Efe, R, Herrmann, K, Ignacio, TJ, Spoorendonk, JA
Published in Value in health (01.01.2022)
Published in Value in health (01.01.2022)
Get full text
Journal Article
Abstract P1-02-02: ESR1 mutations in circulating tumor cell versus circulating cell-free DNA of metastatic breast cancer patients before first-line endocrine therapy and at progression
Sieuwerts, AM, Beije, N, Kraan, J, Van, M, Onstenk, W, Vitale, SR, van der Vlugt – Daane, M, Hamberg, P, Dirix, LY, Brouwers, A, de Jongh, FE, Jager, A, Seynaeve, CM, Jansen, MPHM, Foekens, JA, Martens, JWM, Sleijfer, S
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Effects of CYP induction by rifampicin on tamoxifen exposure
Binkhorst, L, van Gelder, T, Loos, W J, de Jongh, F E, Hamberg, P, Moghaddam-Helmantel, I M Ghobadi, de Jonge, E, Jager, A, Seynaeve, C, van Schaik, R H N, Verweij, J, Mathijssen, R H J
Published in Clinical pharmacology and therapeutics (01.07.2012)
Published in Clinical pharmacology and therapeutics (01.07.2012)
Get more information
Journal Article
Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients
DE JONGH, F. E, VAN VEEN, R. N, VELTMAN, S. J, DE WIT, R, VAN DER BURG, M. E. L, VAN DEN BENT, M. J, PLANTING, Asth, GRAVELAND, W. J, STOTER, G, VERWEIJ, J
Published in British journal of cancer (22.04.2003)
Published in British journal of cancer (22.04.2003)
Get full text
Journal Article
P2-17-04: Induction of Tamoxifen Metabolism by Rifampicin: A Worrying Drug-Drug Interaction
Binkhorst, L, Loos, WJ, de, Jongh FE, Hamberg, P, Ghobadi, Moghaddam-Helmantel IM, Jager, A, Seynaeve, C, Verweij, J, van, Gelder T, Mathijssen, RH
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Get full text
Journal Article
Abstract P1-12-05: First-line chemotherapy with pegylated liposomal doxorubicin versus capecitabine in elderly patients with metastatic breast cancer: results of the phase III OMEGA study of the Dutch Breast Cancer Trialists' Group (BOOG)
Smorenburg, CH, Seynaeve, C, Wymenga, MANM, Maartense, E, de Graaf, H, de Jongh, FE, Braun, HJ, Los, M, Schrama, JG, Portielje, JEA, Hamaker, M, van Tinteren, H, de Groot, SM, van Leeuwen-Stok, EAE, Nortier, HWR
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article
Body-Surface Area–Based Dosing Does Not Increase Accuracy of Predicting Cisplatin Exposure
DE JONGH, Felix E, VERWEIJ, Jaap, LOOS, Walter J, DE WIT, Ronald, DE JONGE, Maja J. A, PLANTING, André S. T, NOOTER, Kees, STOTER, Gerrit, SPARREBOOM, Alex
Published in Journal of clinical oncology (01.09.2001)
Published in Journal of clinical oncology (01.09.2001)
Get full text
Journal Article
Evaluation of an Alternate Dosing Strategy for Cisplatin in Patients With Extreme Body Surface Area Values
LOOS, Walter J, DE JONGH, Felix E, SPARREBOOM, Alex, DE WIT, Ronald, VAN BOVEN-VAN ZOMEREN, Desiree M, STOTER, Gerrit, NOOTER, Kees, VERWEIJ, Jaap
Published in Journal of clinical oncology (01.04.2006)
Published in Journal of clinical oncology (01.04.2006)
Get full text
Journal Article
Population pharmacokinetics of cisplatin in adult cancer patients
DE JONGH, Felix E, GALLO, James M, SHEN, Meiyu, VERWEIJ, Jaap, SPARREBOOM, Alex
Published in Cancer chemotherapy and pharmacology (01.08.2004)
Published in Cancer chemotherapy and pharmacology (01.08.2004)
Get full text
Journal Article
Cisplatin-induced encephalopathy and seizures
Steeghs, N, de Jongh, F E, Sillevis Smitt, P A E, van den Bent, M J
Published in Anti-cancer drugs (01.07.2003)
Published in Anti-cancer drugs (01.07.2003)
Get more information
Journal Article
Dose-dense cisplatin/paclitaxel: a well-tolerated and highly effective chemotherapeutic regimen in patients with advanced ovarian cancer
de Jongh, F.E, de Wit, R, Verweij, J, Sparreboom, A, van den Bent, M.J, Stoter, G, van der Burg, M.E.L
Published in European journal of cancer (1990) (01.10.2002)
Published in European journal of cancer (1990) (01.10.2002)
Get full text
Journal Article
Survival and prognostic indicators in HBsAg-positive liver cirrhosis
da Man, RA, de Jongh, FE, Janssen, HLA, Schalm, SW, Hop, WCJ, van Blankenstein, M
Published in Journal of hepatology (1991)
Published in Journal of hepatology (1991)
Get full text
Journal Article